Search Login Register
Hemianopsia
(Bitemporal Hemianopsia)
Summary
157
relevant articles (7 outcomes,
9 trials/studies)
found for this Disease
Description:
Partial or complete loss of vision in one half of the visual field(s) of one or both eyes. Subtypes include altitudinal hemianopsia, characterized by a visual defect above or below the horizontal meridian of the visual field. Homonymous hemianopsia refers to a visual defect that affects both eyes equally, and occurs either to the left or right of the midline of the visual field. Binasal hemianopsia consists of loss of vision in the nasal hemifields of both eyes. Bitemporal hemianopsia is the bilateral loss of vision in the temporal fields. Quadrantanopsia refers to loss of vision in one quarter of the visual field in one or both eyes.
Also Known As:
Bitemporal Hemianopsia; Binasal Hemianopsia; Homonymous Hemianopsia; Bitemporal Hemianopia; Quadrantanopia Show All >>
Key Drugs and Agents for Hemianopsia
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
2-chloroethyl methyl sulfide
:
1 outcome 1 study in 1 result
: IBA
-
Prolactin
:
1 outcome in 4 results
: IBA
-
Retinaldehyde (Retinal)
:
1 study in 20 results
: IBA
-
Direction compound
:
1 study in 5 results
: IBA
-
glucuronyl glucosamine glycan sulfate (Vessel)
:
1 study in 4 results
: IBA
-
Growth Hormone (Somatotropin)
:
1 study in 1 result
: IBA
-
Amobarbital (Amsal)
:
1 study in 1 result
: IBA
-
Bromocriptine (Parlodel)
:
7 results
:
FDA 5
Generic
-
Triad
:
7 results
:
FDA 1
-
Vigabatrin
:
2 results
: IBA
Show All >>
Diseases Related to Hemianopsia
-
Paresis (Hemiparesis)
-
Seizures (Seizure)
-
Aphasia (Dysphasia)
-
Paralysis (Palsy)
-
Hemiplegia (Spastic Hemiplegia)
Show All >>
Key Therapies for Hemianopsia
Efficacy Chart >>
-
Aftercare (After-Treatment)
:
1 outcome in 9 results
-
Pallidotomy
:
1 outcome in 4 results
-
Ventriculoperitoneal Shunt
:
1 outcome in 3 results
-
Decompression
:
1 outcome in 1 result
-
Contact Lenses
:
1 outcome in 1 result
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.